AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Pharmarise Holdings Corporation
  3. Financials
  4. EBITDA

Pharmarise Holdings Corporation【JP:2796】

Market cap
¥6.2B
P/E ratio
21.8x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
May 31, 20251,023-33.09%
May 31, 20241,529-24.57%
May 31, 20232,027-4.75%
May 31, 20222,128+14.90%
May 31, 20211,852+19.02%
May 31, 20201,556+32.88%
May 31, 20191,171-35.12%
May 31, 20181,805+67.28%
May 31, 20171,079-22.98%
May 31, 20161,401-16.96%
May 31, 20151,687-18.09%
May 31, 20142,060

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)